<DOC>
	<DOCNO>NCT01011504</DOCNO>
	<brief_summary>The objective study determine utilisation pattern patient receive Angiox® participate European centre . Additionally , collection descriptive safety outcome data , study contribute Risk Management strategy Europe</brief_summary>
	<brief_title>Utilisation Angiox® European Practice</brief_title>
	<detailed_description />
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Eligible , receive treatment Angiox® . Willing able provide write informed consent use data accordance relevant local Data Protection law , policy regulation Participation interventional clinical research study involve evaluation investigational drug , include Angiox® , device time enrolment . Patients eligible treatment Angiox® .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>